US20220151533A1 - Method and system for continuous monitoring of patients for arrthymias - Google Patents

Method and system for continuous monitoring of patients for arrthymias Download PDF

Info

Publication number
US20220151533A1
US20220151533A1 US17/529,185 US202117529185A US2022151533A1 US 20220151533 A1 US20220151533 A1 US 20220151533A1 US 202117529185 A US202117529185 A US 202117529185A US 2022151533 A1 US2022151533 A1 US 2022151533A1
Authority
US
United States
Prior art keywords
ecg
data
electrodes
rhythm
waveform
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US17/529,185
Other languages
English (en)
Inventor
Jim Moon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Neuranics Ltd
Original Assignee
Trivirum Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Trivirum Inc filed Critical Trivirum Inc
Priority to US17/529,185 priority Critical patent/US20220151533A1/en
Publication of US20220151533A1 publication Critical patent/US20220151533A1/en
Priority to US18/386,212 priority patent/US11969252B2/en
Assigned to Neuranics Limited reassignment Neuranics Limited ASSIGNMENT OF ASSIGNOR'S INTEREST Assignors: TriVirum, Inc.
Abandoned legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
    • A61B5/7225—Details of analogue processing, e.g. isolation amplifier, gain or sensitivity adjustment, filtering, baseline or drift compensation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/0002—Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network
    • A61B5/0004—Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network characterised by the type of physiological signal transmitted
    • A61B5/0006—ECG or EEG signals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/24—Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
    • A61B5/25—Bioelectric electrodes therefor
    • A61B5/251—Means for maintaining electrode contact with the body
    • A61B5/256—Wearable electrodes, e.g. having straps or bands
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/24—Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
    • A61B5/25—Bioelectric electrodes therefor
    • A61B5/251—Means for maintaining electrode contact with the body
    • A61B5/257—Means for maintaining electrode contact with the body using adhesive means, e.g. adhesive pads or tapes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/24—Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
    • A61B5/316—Modalities, i.e. specific diagnostic methods
    • A61B5/318—Heart-related electrical modalities, e.g. electrocardiography [ECG]
    • A61B5/333—Recording apparatus specially adapted therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/24—Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
    • A61B5/316—Modalities, i.e. specific diagnostic methods
    • A61B5/318—Heart-related electrical modalities, e.g. electrocardiography [ECG]
    • A61B5/339—Displays specially adapted therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/24—Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
    • A61B5/316—Modalities, i.e. specific diagnostic methods
    • A61B5/318—Heart-related electrical modalities, e.g. electrocardiography [ECG]
    • A61B5/346—Analysis of electrocardiograms
    • A61B5/349—Detecting specific parameters of the electrocardiograph cycle
    • A61B5/361—Detecting fibrillation
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H40/00—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
    • G16H40/60—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices
    • G16H40/63—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for local operation
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/30—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indices; for individual health risk assessment
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B2505/00—Evaluating, monitoring or diagnosing in the context of a particular type of medical care
    • A61B2505/07—Home care
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B2562/00—Details of sensors; Constructional details of sensor housings or probes; Accessories for sensors
    • A61B2562/02—Details of sensors specially adapted for in-vivo measurements
    • A61B2562/0219—Inertial sensors, e.g. accelerometers, gyroscopes, tilt switches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/24—Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
    • A61B5/316—Modalities, i.e. specific diagnostic methods
    • A61B5/318—Heart-related electrical modalities, e.g. electrocardiography [ECG]
    • A61B5/346—Analysis of electrocardiograms
    • A61B5/349—Detecting specific parameters of the electrocardiograph cycle
    • A61B5/352—Detecting R peaks, e.g. for synchronising diagnostic apparatus; Estimating R-R interval
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/68—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
    • A61B5/6801—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be attached to or worn on the body surface
    • A61B5/6813—Specially adapted to be attached to a specific body part
    • A61B5/6823—Trunk, e.g., chest, back, abdomen, hip

Definitions

  • the present invention relates to continuous cardiac monitoring of individuals for arrythmias.
  • Atrial fibrillation is a supraventricular tachyarrhythmia with uncoordinated atrial activation and consequently ineffective atrial contraction.
  • Characteristics on an electrocardiogram include 1) irregular R-R intervals (when atrioventricular (AV) conduction is present), 2) absence of distinct repeating P waves, and 3) irregular atrial activity.
  • AF may be triggered by potentially reversible, or acute, causes such as surgery (cardiac and noncardiac), hyperthyroidism, myocarditis or pericarditis, myocardial infarction, pulmonary embolism, pneumonia, and alcohol intoxication.
  • the systems and methods described herein reduce the amount of storage that is required to make diagnostic decisions regarding the presence or absence of the arrhythmia in question by only storing segments of the patient's electrocardiogram during the onset and the offset of the arrhythmia, thus providing many hours of monitoring capacity in a small and easily worn form factor.
  • the present invention relates to a body-worn ECG monitor that captures and records snippets of ECG waveform data that brackets an onset of a change in cardiac rhythm. While described hereinafter in terms of capturing onset or termination of an arrhythmia (e.g., a transition from normal sinus rhythm to atrial fibrillation, or from atrial fibrillation to normal sinus rhythm), the devices and systems described herein are applicable to any abrupt change in cardiac rhythm that may be observed through the use of ECG waveform analysis.
  • an arrhythmia e.g., a transition from normal sinus rhythm to atrial fibrillation, or from atrial fibrillation to normal sinus rhythm
  • the body-worn ECG monitor of the invention comprises:
  • the time lengths l 2 , l 3 , l 4 , and l 5 are preferably selected to capture a desired number of cardiac cycles before and after the event trigger (an identified change in rhythm). For example, in an individual with a normal sinus pulse rate of 60 bpm, 10 seconds would be expected to capture 10 normal cardiac cycles.
  • l 2 and l 4 can be the same time length, and the time lengths time lengths l 3 and is can be the same time length.
  • time lengths l 2 and l 3 are selected to provide at least about 10 seconds of recorded data that includes the first rhythm transition; or between about 10 and about 240 seconds of recorded data that includes the first rhythm transition; or between about 60 and about 120 seconds of recorded data that includes the first rhythm transition.
  • time lengths l 4 and l 5 are selected to provide at least about 10 seconds of recorded data that includes the second rhythm transition; or between about 10 and about 240 seconds of recorded data that includes the second rhythm transition; or between about 60 and about 120 seconds of recorded data that includes the second rhythm transition.
  • the circular data buffer holds at least a portion of the digital waveform equal to l 2 or l 4 , whichever is greater in order to provide a look-back into the previous cardiac cycles sufficient for recording of the desired data snippet. For example, if a first rhythm transition occurs at time t, and l 2 seeks to recover data from the circular data buffer beginning from a point in the data preceding the first rhythm transition by a predetermined time length l 2 , then l 1 (the size of the buffer) must equal or greater than l 2 in order to obtain the necessary data.
  • the first and second rhythm transitions are identified by calculating a randomness score for a series of R-R intervals from the digital waveform using the processing component.
  • randomness scores include an entropy values calculated using methods known in the art as Approximate Entropy (ApEn), Sample Entropy (SampEn), Permutation Entropy (PermEn), and Multi-Scale Entropy (MSE). This list is not meant to be limiting.
  • the randomness score (e.g., entropy value) is calculated for at least about 32, more preferably at least about 64, even more preferably about 128, and still more preferably about 256 or more consecutive QRS complexes in the digital waveform.
  • the body-worn ECG monitor according to the invention is further configured to communicate with an external device to download data stored in the storage memory (e.g., a flash memory) to a storage medium on the external device.
  • the connection between the storage memory in the ECG monitor and the external device may be a direct wired (e.g., WiFi, USB, Ethernet, Firewire, I2C, RS422, CAN, etc.) or wireless (e.g., Bluetooth, Zigbee, ANT+, infrared, etc.) data connection managed by the processing component of the ECG monitor (e.g., a microprocessor or microcontroller).
  • reading the storage memory of the ECG monitor may be managed by the external device through an adapter connected between the storage memory itself and a compatible port on the external device.
  • the body-worn ECG monitor according to the invention may be connected to electrodes that provide the at least one ECG lead by external cabling or wirelessly by means of a transceiver operably connected to the electrodes which communicates with the sensor electronics and the processing component worn separately from the electrodes.
  • the electrodes that provide the at least one ECG lead are provided in the form of an integral or unitary device which further comprises the sensor electronics and the processing component.
  • a single lead ECG monitor may comprise a pair of electrodes on the underside of a flexible body coupled to a housing as an integral or unitary device. Two electrode traces in the flexible body connect to the sensor electronics, which is in turn connected to the processing component. The ECG monitor is then affixed to the individual being monitored by means of an adhesive on the flexible body on the chest at about the level of the heart such that one of the electrodes is positioned superior relative to the other.
  • This provides a “modified lead II” configuration that is adequate for determining rhythm and for observing the presence or absence of p-waves.
  • the present invention relates to such an integral or unitary single lead ECG monitor.
  • the single lead ECG monitor of the present invention comprises an accelerometer within the housing that is coupled to the processing component such that the processing component can determine an orientation of the two electrodes and thereby determine which electrode is superior to the other on the body.
  • the “up/down” orientation of the monitor is not critical when being affixed to the individual. This can provide improved ease of use, particularly in an environment where the single lead ECG monitor is intended to be affixed by the wearer themselves rather than by a medical practitioner, as there is no “wrong” orientation. Rather, the device itself understands the orientation of the single lead ECG monitor on the body from the accelerometer signals and adapts the ECG waveforms accordingly for processing.
  • the orientation of the monitor is determined by the polarity of the signal received from the modified lead II electrodes.
  • the processing component can read the waveform and “flip” the sign of the waveform as required to obtain the correct polarity. Again, the “up/down” orientation of the monitor is not critical when being affixed to the individual.
  • the present invention relates to a system, comprising,
  • the external device may be any computing device capable of receiving data from the ECG monitor and displaying the data.
  • a tablet, personal computer, smartphone, etc., running the necessary computer code is capable of displaying graphical depictions of ECG waveform segments either on screen or in printed form.
  • the present invention comprises a method of continuously monitoring a patient for cardiac electrical signals and identifying rhythm abnormalities.
  • These methods comprise affixing the body worn monitor to the individual, the affixing comprising placing two or more electrodes on the individual that provide the at least one ECG lead, and causing the processing component operably connected to the sensor electronics to receive the digital waveform from the at least one ECG lead and to continuously monitor the digital waveform for changes in cardiac rhythm indicative of a transient arrhythmic event as described above.
  • the present invention provides a single lead ECG monitor, comprising
  • the orientation of the electrodes on the individual is determined by causing the processing component to initially assign an orientation of the electrodes. That is, one of the electrodes is assumed to be the negative electrode and thus considered to be in a superior position to relative to a second electrode of the pair of electrodes for purposes of producing the ECG data. From the ECG waveform collected under this assumed orientation, the processing component determines a polarity metric. If the polarity metric indicates that the initial orientation assigned to the electrodes was incorrect, the processing component reassigns the electrode pair; that is, the second electrode of the pair of electrodes becomes the negative (superior) electrode for purposes of producing ECG data from the waveform. Conversely, if the polarity metric indicates that the initial orientation assigned to the electrodes was correct, the first electrode of the pair of electrodes remains the negative (superior) electrode for purposes of producing ECG data from the waveform
  • the polarity may be determined from one or more of (a) a slope of the leading edge of the QRS complex, (b) an amplitude of the largest positive wave, (c) an amplitude of the deepest negative wave, (d) a polarity of the R wave, (e) a polarity of the T-wave, and (f) a polarity of the P-wave.
  • the polarity metric can comprise one or more of the following determinations:
  • the choice of polarity metric may be encoded in a storage memory of the processing component, and may be dependent upon the electrical activity of the individual being monitored.
  • primary T-wave inversions are associated with benign syndromes, such as the persistent juvenile T-wave pattern and the digitalis effect, as well as morbid conditions, including acute coronary ischemic events, pulmonary embolism, myocarditis, etc.
  • Secondary T-wave changes result from aberrant ventricular activation in the context of normal action potential characteristics; examples include bundle-branch blocks, ventricular pre-excitation states (eg, Wolff-Parkinson-White syndrome), ventricular paced rhythms, and ventricular ectopic beats.
  • Altered P wave morphology may be seen in left or right atrial enlargement. The medical practitioner may consider the cardiac electrical activity of each individual patient in determining a suitable polarity metric.
  • the polarity metric is determined from data in the digital ECG waveform representing a plurality of consecutive cardiac cycles.
  • the polarity metric is determined from data in the digital ECG waveform representing at least 2, 5, 10, 20, 50, or more consecutive cardiac cycles.
  • the processing component of the single lead ECG monitor only assigns an orientation if at least 70%, 75%, 80%, 85%, 90%, 95% or more of the selected number of consecutive cardiac cycles agree on the orientation of the electrodes before the polarity metric is used to produce the ECG data.
  • the monitor can restart the determination with the next 10 consecutive cardiac cycles, and continue until the 80% threshold is met or the system reaches a time-out condition that instructs the single lead ECG monitor to halt and signal an error condition. If an error condition is signaled, the individual can be instructed to remove and reattach the single lead ECG monitor, obtain a replacement, or contact a health care provider for instructions.
  • the monitor can determine if the single lead ECG monitor has been dislodged from the individual based on a loss of signal. This dislodgement may be accidental or when the individual temporarily removes the device.
  • the orientation of the electrodes is may be redetermined by the processing component when the processing component determines from the digital ECG waveform that at least one of the pair of electrodes has been lost, but has now been repositioned on the individual. In other embodiments, the orientation of the electrodes may be redetermined at a predetermined interval during continued use of the ECG data system to confirm that the single lead ECG monitor has remained in its previous orientation.
  • the single lead ECG monitor continuously monitors the digital ECG waveform, and in preferred embodiments the single lead ECG monitor monitors the individual for changes in cardiac rhythm indicative of a transient arrhythmic event such as atrial fibrillation.
  • the processing component can provide a warning, either on the single lead ECG monitor itself or on a remote device.
  • the warning could be from a sound, a blinking light or a vibration of the single lead ECG monitor.
  • the aspect of the device would allow the user to know he/she has an abnormal waveform and contact the health care professional.
  • the single lead ECG monitor can wirelessly signal a remote monitoring station directly without action by the individual.
  • the single lead ECG monitor according to the invention is further configured to communicate with an external device to download data stored in the storage memory (e.g., a flash memory) to a storage medium on the external device.
  • the connection between the storage memory in the ECG monitor and the external device may be a direct wired (e.g., WiFi, USB, Ethernet, Firewire, I2C, RS422, CAN, etc.) or wireless (e.g., Bluetooth, Zigbee, ANT+, infrared, etc.) data connection managed by the processing component of the single lead ECG monitor (e.g., a microprocessor or microcontroller).
  • reading the storage memory of the single lead ECG monitor may be managed by the external device through an adapter connected between the storage memory itself and a compatible port on the external device.
  • the external device further comprises a non-volatile memory operably connected to the microprocessor, wherein the microprocessor is configured to execute code stored on the non-volatile memory, wherein executing the code causes the external device to display the data downloaded to the storage medium as graphical depictions of ECG data; and executing the code on the microprocessor to display the ECG data.
  • the single lead ECG monitor according to the invention may be connected to electrodes that provide the at least one ECG lead by external cabling or wirelessly by means of a transceiver operably connected to the electrodes which communicates with the sensor electronics and the processing component worn separately from the electrodes.
  • the electrodes that provide the at least one ECG lead are provided in the form of an integral or unitary device which further comprises the sensor electronics and the processing component.
  • single lead ECG monitor may comprise a pair of electrodes on the underside of a flexible body coupled to a housing as an integral or unitary device.
  • Two electrode traces in the flexible body connect to the sensor electronics, which is in turn connected to the processing component.
  • the ECG monitor is then affixed to the individual being monitored, e.g., by means of an adhesive on the flexible body, on the chest at about the level of the heart such that one of the electrodes is positioned superior relative to the other.
  • This provides the “modified lead II” configuration that is adequate for determining rhythm and for observing the presence or absence of p-waves.
  • the present invention relates to such an integral or unitary single lead ECG monitor.
  • the single lead ECG monitor captures and records snippets of ECG waveform data that brackets an onset of a change in cardiac rhythm. While described hereinafter in terms of capturing onset or termination of an arrhythmia (e.g., a transition from normal sinus rhythm to atrial fibrillation, or from atrial fibrillation to normal sinus rhythm), the devices and systems described herein are applicable to any abrupt change in cardiac rhythm that may be observed through the use of ECG waveform analysis. by
  • the single lead ECG monitor of the invention can be affixed to the individual to be monitored using a variety of attachment mechanisms as described hereinafter.
  • the single lead ECG monitor is configured to attach to the individual by means of an adhesive on the flexible body of the single lead ECG monitor.
  • the present invention provides methods for monitoring a cardiac electrical activity in an individual, comprising:
  • affixing a single lead ECG monitor according to the invention to the patient receiving a digital ECG waveform at the processing component; executing code on the processing component to determine an orientation of the electrodes on the individual; and recording ECG data having standard lead II polarity for a period of time based on the orientation of the electrodes determined by the processing component from the digital waveform, wherein the ECG data is stored in a storage memory of the single lead ECG monitor.
  • the stored ECG data may be the raw waveform data, or may be a processed form thereof, and may be continuous data or may be discontinuous data snippets.
  • the ECG data in the storage memory of the single lead ECG monitor may be accessed by an external device.
  • the method further comprises operably connecting the ECG monitor to an external device comprising a microprocessor and a storage medium; and downloading the recorded ECG data to the storage medium.
  • FIG. 1 depicts an exemplary hardware implementation for use in the present invention in schematic form.
  • FIG. 2 depicts the general strategy for an exemplary ECG monitor of the present invention in additional detail.
  • FIG. 3 depicts an exemplary ECG recording scheme for the ECG monitor.
  • FIG. 4 depicts a conventional axial reference system for ECG monitor of the invention showing augmented leads aV L , aV R , and aV F .
  • FIG. 5 depicts an example of the system for using the devices of the invention is provided in FIG. 5 .
  • the heart is depolarized to trigger its contraction.
  • the wave of depolarization spreads across the atria to the atrioventricular node (AVN).
  • the impulse is delayed briefly at the AVN and atrial contraction is completed.
  • the wave of depolarization then proceeds rapidly to the bundle of His where it splits into two pathways and travels along the right and left bundle branches.
  • the impulse travels the length of the bundles along the interventricular septum to the base of the heart, where the bundles divide into the Purkinje system. From here, the wave of depolarization is distributed to the ventricular walls and initiates ventricular contraction.
  • the ECG is a recording of the heart's electrical activity during this “cardiac cycle”.
  • the electrical signals indicative of the cardiac cycle may be sensed as changes in electrical potential between two measurement points on the body. Depending on the number of electrodes and their position on the body, multiple views of the heart's electrical activity can be recorded.
  • An ECG “lead” is a measure of differences in potential measured between two points.
  • a simple lead is composed of two electrodes; a negative (reference) electrode and a positive (exploring) electrode.
  • a standard 12-lead ECG uses 10 electrodes to obtain 12 electrical measurements of the heart.
  • Three bipolar leads and three unipolar leads are obtained from three electrodes attached to the left arm, the right arm, and the left leg, respectively.
  • An electrode is also attached to the right leg as a ground electrode. These electrodes provide the following leads:
  • the unipolar leads reflect the potential difference between one of the three limb electrodes and an estimate of zero potential—derived from the remaining two limb electrodes.
  • augmented leads These leads are known as augmented leads.
  • the augmented leads and their respective limb electrodes are:
  • Lead II for example, records the electrical activity as seen from the inferior (diaphragmatic) surface of the heart along a plane that is approximately vertical through the heart. See, FIG. 4 .
  • the reference electrode is superior to the exploring electrode.
  • a “modified” lead II may be provided by positioning a pair of electrodes on the chest at about the level of the heart, with one electrode being positioned superior to the other.
  • this modified lead II orientation of the electrodes can be advantageous to use as a single lead system, as this is both simple and provides the necessary data to assess an arrhythmia such as atrial fibrillation.
  • ECG lead II a wave a depolarization traveling toward the exploring electrode produces a positive deflection in the lead, and a maximal positive deflection is recorded in lead II when the depolarization wave travels parallel to sampled the axis.
  • the device By providing an accelerometer in the device, it is unnecessary to predefine which of the two electrodes is the reference (superior) electrode. Rather, the device can be placed on the monitored individual with either electrode in the superior position, and the device itself can determine the orientation of the electrodes and thus correctly measure the potential difference between these electrodes. Alternatively, the device can determine the polarity of the incoming lead waveform and invert the sign of the signal so that whichever electrode in the lead is supposed to be the positive lead is read as positive.
  • the R-R interval measurement begins with the identification of a QRS complex distinct from any noise or artifact that may be present, and the further identification of a consistent fiducial point within the QRS complex.
  • the associated R-R interval is the time between the newly determined fiducial point and a corresponding fiducial point in the previous QRS complex. Because the sample rate of the ECG waveform determines the resolution of the R-R interval, it must be fast enough to provide adequate differentiation in the subsequent randomness calculation of the R-R intervals to distinguish atrial fibrillation from non-atrial fibrillation rhythms.
  • the determination of the fiducial point of the QRS complex begins with the determination and removal of the noise elements of the signal. This is accomplished with a band-pass (e.g., 5 to 50 Hz) filter followed by a series of signal processing steps that determine the time varying signal energy in the in-band signal, where the in-band signal energy is defined as:
  • Y is the number of samples within the window and E s (n ⁇ y/2) is the energy at n ⁇ y/2.
  • the energy peaks that also meet criteria for polarity and duration are selected as the QRS complex, with the point of peak energy chosen as the fiducial point that marks the time of the R-wave.
  • the time of the newly detected R-wave minus the time of the previous R-wave detection is the R-R interval that is passed to the atrial fibrillation detection algorithm.
  • FIG. 2 depicts the general strategy for an exemplary ECG monitor of the present invention.
  • An electrocardiogram is acquired from a patient (1) by means of electrodes attached to the patient.
  • the signal from the electrodes is amplified (2) and filtered (3) to achieve the desired signal bandwidth.
  • the filtered electrocardiogram is converted to a digital data stream by an analog-to-digital converter (4) and stored in a circular data buffer (5).
  • the number of storage locations in the circular buffer is sufficient to store a history of the electrocardiogram for a duration that provides sufficient information to clear observe the patient's cardiac rhythm for a period of time prior to the onset of atrial fibrillation or other arrhythmia to confirm that the cardiac rhythm preceding the arrhythmia of interest (e.g.
  • An arrhythmia detection algorithm (6) evaluates the cardiac rhythm in real time and, upon detection, provides a control signal to the memory write control element (7) to begin storing the historical electrocardiogram into the electrocardiogram storage memory (8).
  • the arrhythmia detection algorithm (6) evaluates the electrocardiogram in real time to detect the cessation of the arrhythmia of interest and signals the memory write control element (7) to record the end of the arrhythmia event with sufficient historical data prior the end of the arrhythmia event to confirm the arrhythmia of interest and to record the transition to a cardiac rhythm that is different from the arrhythmia of interest with sufficient recording time to confirm that the new cardiac rhythm is in fact different from the arrhythmia of interest.
  • the ECG monitor may be affixed and/or adhered to the body of the individual in many ways. For example, with at least one of the following an adhesive tape, a constant-force spring, suspenders around shoulders, a screw-in microneedle electrode, a pre-shaped electronics module to shape fabric to a thorax, a pinch onto roll of skin, or transcutaneous anchoring.
  • the monitor may comprise an adhesiveness embodiment (e.g. chest strap), and/or a low-irritation adhesive for sensitive skin, such as hydrocolloid.
  • the ECG monitor may comprise a layer of breathable tape or fabric for adherence to the wearer, for example a gauze, latex, wrap knit, or other types of stretchable and wear-safe material, such as a Tricot-type linen or tricot-knit polyester fabric, to allow moisture vapor and air to circulate to and from the skin of the patient through the tape.
  • the breathable tape can comprise a backing material that provides an adhesive layer. The backing may be conformable and/or flexible, such that the device does not become detached with body movement.
  • Atrial Fibrillation Rhythm Identification
  • Atrial fibrillation is identified by the random nature of R-R intervals that are characteristic of atrial fibrillation. While several arrhythmias exhibit multiple R-R intervals (e.g. bigeminy or trigemini), they are not random, but repeating patterns. To recognize atrial fibrillation from these other arrhythmias, it is necessary to calculate the true random nature of the R-R intervals over a number of consecutive R-R intervals. Approximate Entropy (ApEn) is a statistical measure of the level of randomness of a data series which is based on counting patterns and their repetitions. Low levels of this statistic indicate the existence of many repeated patterns, and high values indicate randomness and unpredictability.
  • ApEn was originally developed after the entropy concept of Information Theory for physiological research, it has been used in different fields from psychology to finance.
  • Alternatives to ApEn include Sample Entropy (SampEn), Permutation Entropy (PermEn), and Multi-Scale Entropy (MSE). See, e.g., arxiv.org/ftp/arxiv/papers/1512/1512.00725.pdf, which is hereby incorporated by reference.
  • the randomness of 128 consecutive R-R intervals is calculated, updating the computation every time a new R-R interval is measured in a rolling manner, with the oldest R-R interval being removed from the list of R-R intervals every time a new R-R interval is added.
  • the output of the randomness computation is a relative measure of randomness where a value of zero corresponds to a set of R-R intervals that are not random, while an output value of 1 indicates that every R-R interval is truly random, and bears absolutely no relationship between any of the other R-R intervals being evaluated.
  • the response time of the R-R randomness computation can provide the ability to recognize atrial fibrillation in a time sufficiently short to allow for the capture of the ECG waveform starting a number of seconds prior to the transition from a non-atrial fibrillation rhythm to atrial fibrillation such that the transition is captured in a time-limited snippet of the ECG waveform.
  • the calculation of a randomness score is based on concepts developed by Claude Shannon in 1948: given a discrete random variable X, with possible outcomes x 1 , . . . , x n , which occur with probability P(x 1 ), . . . , P(x n ), the entropy of X is formally defined as:
  • the values of xi are the R-R intervals over a range from 1 to n values.
  • the calculations are updated with every new R-R interval such that when the randomness index rises above a threshold, it corresponds to the onset of atrial fibrillation. Similarly, when the randomness index drops below the threshold, it corresponds to the transition from atrial fibrillation to a non-atrial fibrillation rhythm.
  • the value of the index used as the threshold in a preferred embodiment of the invention is 0.72, determined empirically through performance evaluation against industry recognized databases of ECG recordings from patients with atrial fibrillation.
  • FIG. 3 depicts an exemplary ECG recording scheme for the ECG monitor.
  • the device continuously records data in the circular buffer which stores a limited amount of recent historical ECG data.
  • the subject is in normal sinus rhythm (NSR).
  • NSR normal sinus rhythm
  • AF-start Upon detection of the onset of atrial fibrillation (AF-start), a snippet of data is captured from a point 30 seconds before AF-start (obtained from the circular buffer) and terminating 50 seconds after AF-start.
  • AF-end a similar snippet is captured.
  • Each snippet records the transition in rhythm to or from AF and is stored in the storage memory for later review and/or analysis.
  • FIG. 1 depicts an exemplary hardware implementation for use in the present invention.
  • a number of integrated ECG monitoring circuits are available in the art to provide an interface to ECG electrodes for receiving analog input, signal conditioning, analog-to-digital conversion, etc.
  • AD8233 (Analog Devices) provides a suitable ECG front end for the ECG monitors described herein.
  • the AD8233 implements a two-pole, high-pass filter for eliminating motion artifacts and the electrode half cell potential.
  • This filter is tightly coupled with the instrumentation amplifier architecture to allow both large gain and high-pass filtering in a single stage, thereby saving space and cost.
  • An uncommitted operational amplifier enables the AD8233 to create a three-pole, low-pass filter to remove additional noise. The user can select the frequency cutoff of all filters to suit different types of applications.
  • the AD8233 includes a right leg drive (RLD) amplifier for driven electrode applications.
  • RLD right leg drive
  • the AD8233 includes a fast restore function that reduces the duration of the otherwise long settling tails of the high-pass filters. After an abrupt signal change that rails the amplifier (such as a leads off condition), the AD8233 automatically adjusts to a higher filter cutoff. This feature allows the AD8233 to recover quickly, and therefore, to take valid measurements soon after connecting the electrodes to the subject.
  • HM301D ST Microelectronics
  • a fully integrated analog high pass filter removes the DC component of the signal.
  • Each channel input channel provides high resolution and low noise conversion of biopotential signals up to 10 kHz.
  • a digital filtering and preprocessing (DFP)block implements configurable band-pass filters, IQ impedance demodulation and enable specific algorithm implementation for lead-off check and pacemaker detection.
  • An SPI interface allows the exchange of data with both the microcontroller and other HM301D devices in case of chain connection.
  • MAX30003 (Maxim Integrated) is a complete, biopotential, analog front-end solution for wearable ECG applications. It offers high performance for clinical and fitness applications, with ultra-low power for long battery life.
  • the biopotential channel has ESD protection, EMI filtering, internal lead biasing, DC leads-off detection, ultra-low power leads-on detection during standby mode, and extensive calibration voltages for built-in self-test. Soft power-up sequencing ensures no large transients are injected into the electrodes.
  • the biopotential channel also has high input impedance, low noise, high CMRR, programmable gain, various low-pass and high-pass filter options, and a high-resolution analog-to-digital converter.
  • the biopotential channel is DC coupled, can handle large electrode voltage offsets, and has a fast recovery mode to quickly recover from overdrive conditions, such as defibrillation and electrosurgery.
  • the processing component comprises a microprocessor or microcontroller, a memory for storage of data processing instructions, implementation of a circular buffer data structure, and to a storage memory for holding data snippets for later retrieval.
  • An example of a suitable microcontroller is MAX32660 (Maxim Integrated), a 32-bit microcontroller designed for battery-powered devices and wireless sensors. It provides an Arm® Cortex®-M4 processor with floating point unit (FPU); supports SPI, UART, and I 2 C communication; and includes up to 256 KB of flash memory and 96 KB of RAM to accommodate application and sensor code.
  • MAX32660 Maxim Integrated
  • FPU floating point unit
  • STM32L4 ST Microelectronics
  • ARM® Cortex®-M4 32-bit core operating at a frequency of up to 80 MHz and featuring a FPU, a full set of DSP instructions and a memory protection unit (MPU) which enhances application security. It offers up to 2 Mbyte of Flash (dual bank) and up to 640 Kbytes of SRAM.
  • the entire system performance is optimized using a multi-AHB bus matrix and DMA controllers. It supports I 2 C communication
  • a circular buffer is a data structure that uses a fixed-size buffer as if it were connected end-to-end. Circular buffering makes a good implementation strategy for a queue that has fixed maximum size. Should a maximum size be adopted for a queue, then a circular buffer is a completely ideal implementation; all queue operations are constant time.
  • a circular buffer can be implemented using four pointers, or two pointers and two integers:
  • the circular buffer is implemented for direct memory access (DMA).
  • DMA Direct Memory Access
  • embedded microcontroller systems it is common to have a single core CPU.
  • most advanced microcontrollers have a Direct Memory Access (DMA) controller. As its name says—DMA does data transfers between memory locations without the need of CPU.
  • MT25QU256ABA (Micron Technology) is a 256 Mb, 1.8V Multiple I/O Serial Flash Memory providing It a high-speed SPI-compatible bus interface, execute-in-place (XIP) functionality, advanced write protection mechanisms, and extended address access.
  • XIP execute-in-place
  • a patient may remove the ECG monitor, place it in a (prepaid) mailing pouch, and the device to a data processing facility.
  • the stored data snippets may be downloaded and the data may then be analyzed by any suitable method and then provided in the form of a report.
  • the stored data may be accessed wirelessly (e.g., Bluetooth, ZigBee, WiFi (802.11), Wireless USB, ANT or ANT+, Ultrawideband (UWB), IrDA, NFC, etc.) or by wired means (e.g., I2C, USB, Serial, TDMA, etc.),
  • a TC2050-IDC (Tag-Connect) or other similar connector can be provided on the ECG monitor to permit serial wire debug and JTAG access to the processing system, including directly connecting to the Flash memory unit of the ECG monitor for downloading data to an external computing device.
  • the external device used for data analysis may vary. For example, analysis may occur on a smartphone, tablet or PC. Alternatively, analysis may occur a server or other processing device and displayed via a network connection to a remote viewing device. The analysis may also occur using cloud-based distributed processing resources.
  • Medical information poses significant challenges to knowledge management systems. Medical information includes data that is personal and, while there are legitimate reasons for transmitting medical information files, such transmission must be limited to appropriate circumstances and to authorized recipients.
  • the present devices are designed to prevent the data processing facility from being able to associate a particular device to a particular patient. Specifically, the device is assigned a code, and only the patient's medical practitioner can correlate this code to the patient.
  • the system provides significant protection of protected health information (PHI) while the device is moved by means of the postal or package delivery service, the processing of the device at a location that is not required to observe PHI security protocols, and the return of the ECG test report to the patient's care provider.
  • PHI protected health information
  • FIG. 5 An example of the system for using the devices of the invention is provided in FIG. 5 .
  • the entity responsible for receiving the recorded data from an ECG collection and recording device provides the device to a medical professional.
  • the ECG collection and recording device comprises a unique identifying code stored on a first computer-readable storage medium within the ECG collection and recording device. This unique identifying code is write-protected to prevent unauthorized modification by anyone in the chain of custody of the device, including the medical professional and the patient.
  • the ECG collection and recording device is preferably provided in sealed packaging which is to be mailed to the patient.
  • the medical professional then associates the ECG collection and recording device to the individual patient by storing the unique identifying code in a record corresponding to the individual in a database file system without removal of the ECG collection and recording device from the sealed packaging.
  • This association between the identifying information and the individual is not provided to the analysis entity.
  • the entity responsible for receiving the recorded data from an ECG collection and recording device for analysis cannot know the patient's identity.
  • the medical professional then forwards the ECG collection and recording device to the individual patient in the sealed packaging together with pre-addressed return packaging directing the ECG collection and recording device to the analysis entity.
  • the return packaging provides no identifying information corresponding to the individual to the analysis entity. Rather, the return packaging only contains the unique identifying code stored on a first computer-readable storage medium within the ECG collection and recording device.
  • the individual wears the device, thereby recording ECG data on a computer-readable ECG storage medium within the ECG collection and recording device.
  • the packaging is designed so that removal of the ECG collection and recording device from the sealed packaging and/or positioning of the ECG collection and recording device on the individual's body begins the data collection by the device.
  • the computer-readable ECG storage medium may be the first computer-readable storage medium or a second computer-readable storage medium within the device.
  • the ECG data recorded on the computer-readable ECG storage medium, or a processed form thereof is stored by the analysis entity on data server in a record corresponding to the unique identifying code.
  • This record may be accessible for reading/viewing by the medical professional, who can associate the data to the individual patient despite there being no identifying information corresponding to the individual stored on the data server.
  • the analysis entity creates a report of relevant information extracted from the ECG data to the medical professional using the unique identifying code, which the medical professional can associate with the individual patient. This report may be transmitted in any form, including hard copy or as an electronic file.
  • the association of the device, the report, and the patient identity is known only to the healthcare provider within the provider's HIPPA compliant business environment and relieves the device manufacturer or device processor from the requirement to establish and maintain a HIPPA compliant facility and personnel training and management.
  • a body-worn ECG monitor comprising: at least one ECG lead configured be worn on the body of an individual and to measure electrical signals indicative of electrical activity of the individual's cardiac cycle on a continuous basis and generate therefrom an analog waveform; sensor electronics comprising an analog-to-digital converter operably connected to the at least one ECG lead to receive the analog waveform or a frequency-filtered form thereof and to generate therefrom a digital waveform; a processing component operably connected to the sensor electronics and configured to receive the digital waveform and to continuously monitor the digital waveform for changes in cardiac rhythm indicative of a transient arrhythmic event by
  • “about X” includes a range of values that are ⁇ 20%, ⁇ 10%, ⁇ 5%, ⁇ 2%, ⁇ 1%, ⁇ 0.5%, ⁇ 0.2%, or ⁇ 0.1% of X, where X is a numerical value.
  • the term “about” refers to a range of values which are 10% more or less than the specified value.
  • the term “about” refers to a range of values which are 5% more or less than the specified value.
  • the term “about” refers to a range of values which are 1% more or less than the specified value.
  • ranges of values are merely intended to serve as a shorthand method of referring individually to each separate value falling within the range, unless otherwise indicated herein, and each separate value is incorporated into the specification as if it were individually recited herein.
  • a range used herein, unless otherwise specified, includes the two limits of the range. For example, the terms “between X and Y” and “range from X to Y, are inclusive of X and Y and the integers there between.
  • any range including any of the two individual values as the two end points is also conceived in this disclosure.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Medical Informatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Molecular Biology (AREA)
  • Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Cardiology (AREA)
  • Signal Processing (AREA)
  • Physiology (AREA)
  • Power Engineering (AREA)
  • Computer Vision & Pattern Recognition (AREA)
  • Artificial Intelligence (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Primary Health Care (AREA)
  • Computer Networks & Wireless Communication (AREA)
  • Data Mining & Analysis (AREA)
  • Databases & Information Systems (AREA)
  • Business, Economics & Management (AREA)
  • General Business, Economics & Management (AREA)
  • Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
US17/529,185 2020-11-17 2021-11-17 Method and system for continuous monitoring of patients for arrthymias Abandoned US20220151533A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
US17/529,185 US20220151533A1 (en) 2020-11-17 2021-11-17 Method and system for continuous monitoring of patients for arrthymias
US18/386,212 US11969252B2 (en) 2020-11-17 2023-11-01 Method and system for continuous monitoring of patients for arrhythmias

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063114996P 2020-11-17 2020-11-17
US202163144433P 2021-02-01 2021-02-01
US17/529,185 US20220151533A1 (en) 2020-11-17 2021-11-17 Method and system for continuous monitoring of patients for arrthymias

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US18/386,212 Continuation US11969252B2 (en) 2020-11-17 2023-11-01 Method and system for continuous monitoring of patients for arrhythmias

Publications (1)

Publication Number Publication Date
US20220151533A1 true US20220151533A1 (en) 2022-05-19

Family

ID=81588583

Family Applications (2)

Application Number Title Priority Date Filing Date
US17/529,185 Abandoned US20220151533A1 (en) 2020-11-17 2021-11-17 Method and system for continuous monitoring of patients for arrthymias
US18/386,212 Active US11969252B2 (en) 2020-11-17 2023-11-01 Method and system for continuous monitoring of patients for arrhythmias

Family Applications After (1)

Application Number Title Priority Date Filing Date
US18/386,212 Active US11969252B2 (en) 2020-11-17 2023-11-01 Method and system for continuous monitoring of patients for arrhythmias

Country Status (5)

Country Link
US (2) US20220151533A1 (fr)
EP (1) EP4247261B8 (fr)
AU (1) AU2021381957A1 (fr)
CA (1) CA3199167A1 (fr)
WO (1) WO2022109064A1 (fr)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12232851B2 (en) 2021-03-08 2025-02-25 Medtronic, Inc. Acute health event monitoring
US12521022B2 (en) 2021-03-08 2026-01-13 Medtronic, Inc. Acute health event monitoring and alerting
US12558036B2 (en) 2021-03-08 2026-02-24 Medtronic, Inc. Acute health event monitoring and verification

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20220151533A1 (en) * 2020-11-17 2022-05-19 TriVirum, Inc. Method and system for continuous monitoring of patients for arrthymias

Citations (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4295474A (en) * 1979-10-02 1981-10-20 The Johns Hopkins University Recorder with patient alarm and service request systems suitable for use with automatic implantable defibrillator
US5732708A (en) * 1996-08-09 1998-03-31 Pacesetter, Inc. Method for storing EGM and diagnostic data in a read/write memory of an implantable cardiac therapy device
US6415174B1 (en) * 1998-11-09 2002-07-02 Board Of Regents The University Of Texas System ECG derived respiratory rhythms for improved diagnosis of sleep apnea
US7447544B1 (en) * 2004-02-18 2008-11-04 Pacesetter, Inc. System and method for controlling the recording of diagnostic medical data in an implantable medical device
US20090112110A1 (en) * 2007-10-24 2009-04-30 Siemens Medical Solutions Usa, Inc. System for Cardiac Medical Condition Detection and Characterization
US20120302905A1 (en) * 2011-05-27 2012-11-29 General Electric Company Method, apparatus and computer program product for monitoring physiological signals
US8460189B2 (en) * 2007-09-14 2013-06-11 Corventis, Inc. Adherent cardiac monitor with advanced sensing capabilities
US20140276096A1 (en) * 2013-03-15 2014-09-18 Bonutti Research, Inc. Systems and methods for use in diagnosing a medical condition of a patient
US20180116536A1 (en) * 2016-11-01 2018-05-03 Medtronic Monitoring, Inc. System and method for onset/offset capture
US20210386326A1 (en) * 2020-06-10 2021-12-16 Ospitek, Inc. System And Method For Live Patient Tracking For Surgical Centers And Hosptials
US20230346292A1 (en) * 2019-07-31 2023-11-02 Koninklijke Philips N.V. Calibrating a sensor
US11969252B2 (en) * 2020-11-17 2024-04-30 TriVirum, Inc. Method and system for continuous monitoring of patients for arrhythmias

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20130109989A1 (en) * 2009-06-17 2013-05-02 Heart Force Medical Inc. Method and apparatus for obtaining and processing ballistocardiograph data
US20110066044A1 (en) * 2009-09-15 2011-03-17 Jim Moon Body-worn vital sign monitor
EP2571420A4 (fr) * 2010-05-21 2018-04-18 Medicomp, INC. Moniteur cardiaque multi-usage rétractable
US9259183B2 (en) * 2012-12-31 2016-02-16 Tosense, Inc. Body-worn sensor for characterizing patients with heart failure
US9408551B2 (en) * 2013-11-14 2016-08-09 Bardy Diagnostics, Inc. System and method for facilitating diagnosis of cardiac rhythm disorders with the aid of a digital computer
US10188867B2 (en) * 2015-01-23 2019-01-29 Medtronic, Inc. Method and apparatus for beat acquisition during template generation in a medical device having dual sensing vectors
US10959634B2 (en) * 2017-05-02 2021-03-30 Nanowear Inc. Wearable congestive heart failure management system

Patent Citations (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4295474A (en) * 1979-10-02 1981-10-20 The Johns Hopkins University Recorder with patient alarm and service request systems suitable for use with automatic implantable defibrillator
US5732708A (en) * 1996-08-09 1998-03-31 Pacesetter, Inc. Method for storing EGM and diagnostic data in a read/write memory of an implantable cardiac therapy device
US6415174B1 (en) * 1998-11-09 2002-07-02 Board Of Regents The University Of Texas System ECG derived respiratory rhythms for improved diagnosis of sleep apnea
US7447544B1 (en) * 2004-02-18 2008-11-04 Pacesetter, Inc. System and method for controlling the recording of diagnostic medical data in an implantable medical device
US8460189B2 (en) * 2007-09-14 2013-06-11 Corventis, Inc. Adherent cardiac monitor with advanced sensing capabilities
US20090112110A1 (en) * 2007-10-24 2009-04-30 Siemens Medical Solutions Usa, Inc. System for Cardiac Medical Condition Detection and Characterization
US20120302905A1 (en) * 2011-05-27 2012-11-29 General Electric Company Method, apparatus and computer program product for monitoring physiological signals
US20140276096A1 (en) * 2013-03-15 2014-09-18 Bonutti Research, Inc. Systems and methods for use in diagnosing a medical condition of a patient
US20180116536A1 (en) * 2016-11-01 2018-05-03 Medtronic Monitoring, Inc. System and method for onset/offset capture
US20230346292A1 (en) * 2019-07-31 2023-11-02 Koninklijke Philips N.V. Calibrating a sensor
US20210386326A1 (en) * 2020-06-10 2021-12-16 Ospitek, Inc. System And Method For Live Patient Tracking For Surgical Centers And Hosptials
US11969252B2 (en) * 2020-11-17 2024-04-30 TriVirum, Inc. Method and system for continuous monitoring of patients for arrhythmias

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12232851B2 (en) 2021-03-08 2025-02-25 Medtronic, Inc. Acute health event monitoring
US12521022B2 (en) 2021-03-08 2026-01-13 Medtronic, Inc. Acute health event monitoring and alerting
US12558036B2 (en) 2021-03-08 2026-02-24 Medtronic, Inc. Acute health event monitoring and verification

Also Published As

Publication number Publication date
AU2021381957A1 (en) 2023-06-22
AU2021381957A9 (en) 2025-03-20
WO2022109064A1 (fr) 2022-05-27
EP4247261A1 (fr) 2023-09-27
US11969252B2 (en) 2024-04-30
CA3199167A1 (fr) 2022-05-27
EP4247261A4 (fr) 2024-10-30
US20240057922A1 (en) 2024-02-22
EP4247261B1 (fr) 2026-01-21
EP4247261B8 (fr) 2026-03-04

Similar Documents

Publication Publication Date Title
US11969252B2 (en) Method and system for continuous monitoring of patients for arrhythmias
US11653870B2 (en) System and method for display of subcutaneous cardiac monitoring data
US11647939B2 (en) System and method for facilitating a cardiac rhythm disorder diagnosis with the aid of a digital computer
EP1809173B1 (fr) Surveillance a long terme en vue de la detection d'une fibrillation auriculaire
US8798727B2 (en) Long-term monitoring for discrimination of different heart rhythms
JP6738969B2 (ja) 植込み型心モニタのための徐脈性休止検出
US20120165684A1 (en) Systems and Methods for Heart and Activity Monitoring
US20120197150A1 (en) External cardiac monitor
US11576605B2 (en) System and method for onset/offset capture
US20060276716A1 (en) Atrial fibrillation detection method and apparatus
US6625483B2 (en) Method of noninvasively determining a patient's susceptibility to arrhythmia
US20070073176A1 (en) Method and system for detecting premature ventricular contraction from a surface electrocardiogram
EP3155964B1 (fr) Un procédé et un dispositif de surveillance pour l'analyse de données ecg par la comparaison d'intervalles de temps consécutifs
Mehta Characterization of ECG Signal Using Programmable System on Chip
Cesario et al. Arrhythmia detection with a low-profile wireless adherent cardiac monitor: results from the ADAM and EVE studies
Márquez-Espinoza et al. ECG ambulatory system for long term monitoring of heart rate dynamics
WO2000041622A1 (fr) Technique non invasive permettant de determiner le risque d'arythmie chez un patient

Legal Events

Date Code Title Description
STPP Information on status: patent application and granting procedure in general

Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION

STPP Information on status: patent application and granting procedure in general

Free format text: NON FINAL ACTION MAILED

STPP Information on status: patent application and granting procedure in general

Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER

STPP Information on status: patent application and granting procedure in general

Free format text: NON FINAL ACTION MAILED

STPP Information on status: patent application and granting procedure in general

Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER

STPP Information on status: patent application and granting procedure in general

Free format text: FINAL REJECTION MAILED

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION

AS Assignment

Owner name: NEURANICS LIMITED, UNITED KINGDOM

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:TRIVIRUM, INC.;REEL/FRAME:073603/0393

Effective date: 20251226